← back to search

Daniel Tödt

Bochum University of Applied Sciences · DE
Area of research
Hepatology · Infectious Diseases
Research interest
Research interests include Hepatitis Viruses Studies and Epidemiology, Hepatitis C virus research, Viral gastroenteritis research and epidemiology, and Hepatitis B Virus Studies.
h-index
41
citations
10,230
works
242
NIH funding
primary concept
email

Recent publications

Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants
Proceedings of the National Academy of Sciences 2025cited by 2position: middledoi
TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution
Proceedings of the National Academy of Sciences 2024cited by 15position: middledoi
A Pangenotypic Hepatitis E Virus Replication Inhibitor With High Potency in a Rat Infection Model
Gastroenterology 2024cited by 7position: middledoi
Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients
Hepatology 2023cited by 30position: lastdoi
EGF receptor modulates HEV entry in human hepatocytes
Hepatology 2023cited by 25position: middledoi
Insertions and deletions in the hypervariable region of the hepatitis E virus genome in individuals with acute and chronic infection
Liver International 2023cited by 5position: middledoi
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection
Proceedings of the National Academy of Sciences 2022cited by 73position: middledoi
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization
Cell Reports 2022cited by 55position: middledoi
Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication
Antiviral Research 2022cited by 15position: middledoi
Hepatitis E: An update on One Health and clinical medicine
Liver International 2021cited by 132position: middledoi
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
The Journal of Infectious Diseases 2021cited by 48position: middledoi
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotes
iScience 2021cited by 32position: firstdoi
Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols
Emerging infectious diseases 2020cited by 398position: middledoi
LY6E impairs coronavirus fusion and confers immune control of viral disease
Nature Microbiology 2020cited by 237position: middledoi
Robust hepatitis E virus infection and transcriptional response in human hepatocytes
Proceedings of the National Academy of Sciences 2020cited by 110position: firstdoi
Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health
Pathogens 2020cited by 106position: middledoi
Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E – The HepNet SofE pilot study
Journal of Hepatology 2020cited by 68position: middledoi
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle
Journal of Hepatology 2020cited by 48position: middledoi
Absence of cGAS-mediated type I IFN responses in HIV-1–infected T cells
Proceedings of the National Academy of Sciences 2020cited by 37position: middledoi
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to mice
Science Advances 2020cited by 32position: middledoi
Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies
Gut 2020cited by 31position: middledoi
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
Antiviral Research 2018cited by 82position: firstdoi
Hepatitis E virus replication and interferon responses in human placental cells
Hepatology Communications 2018cited by 57position: middledoi
Immune protection against reinfection with nonprimate hepacivirus
Proceedings of the National Academy of Sciences 2017cited by 51position: middledoi
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome
Gut 2016cited by 176position: firstdoi
Extra‐hepatic replication and infection of hepatitis E virus in neuronal‐derived cells
Journal of Viral Hepatitis 2016cited by 127position: middledoi
Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication
Antimicrobial Agents and Chemotherapy 2016cited by 88position: firstdoi
Hepatitis E Virus (HEV) ORF2 Antigen Levels Differentiate Between Acute and Chronic HEV Infection
The Journal of Infectious Diseases 2016cited by 67position: middledoi
Differential Infection Patterns and Recent Evolutionary Origins of Equine Hepaciviruses in Donkeys
Journal of Virology 2016cited by 46position: middledoi
Interferon‐inducible cholesterol‐25‐hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
Hepatology 2015cited by 85position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eike Steinmann · University Hospitals of the Ruhr-University of Bochum21 papers (2015–2024)Patrick Behrendt · Medizinische Hochschule Hannover12 papers (2015–2023)Heiner Wedemeyer · Ruhr University Bochum9 papers (2016–2023)Florian W. R. Vondran · Medizinische Hochschule Hannover7 papers (2015–2023)Thomas Pietschmann · Medizinische Hochschule Hannover7 papers (2015–2020) · 7 papers (2015–2020)Volker Kinast · University Hospital Heidelberg6 papers (2018–2023)Richard J. P. Brown · Medizinische Hochschule Hannover5 papers (2016–2020)Martina Friesland · Medizinische Hochschule Hannover5 papers (2016–2020)Markus Cornberg · Technische Universität Braunschweig5 papers (2016–2023) · 5 papers (2020–2023)C.–Thomas Bock · Medizinische Hochschule Hannover4 papers (2016–2023)Michael P. Manns · Oslo University Hospital4 papers (2016–2021)Tanvi Khera · Medizinische Hochschule Hannover3 papers (2018–2021)Stephanie Pfaender · Leibniz Institute of Virology (LIV)3 papers (2017–2021)Sven Pischke · Medizinische Hochschule Hannover3 papers (2016–2023)Svenja Hardtke · Universität Hamburg3 papers (2020–2023)Viet Loan Dao Thi · Heidelberg University3 papers (2018–2023)Johan Neyts · KU Leuven3 papers (2016–2024)Christine Goffinet · Sunshine Coast University Hospital3 papers (2015–2021)